The Internal Revenue Service remained mostly silent during a May 16 public hearing convened to solicit comments from stakeholders on the impending 2.3% excise tax on U.S. device sales.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?